A Johns Hopkins University study in Baltimore indicates many U.S. physicians are ill-prepared to diagnose or treat bioterrorism diseases.
The researchers said more than one-half of 631 physicians tested were unable to correctly diagnose diseases caused by agents most likely to be used by bioterrorists -- smallpox, anthrax, botulism and plague.
However, test scores improved dramatically for the same physicians after they completed an online training course in diagnosing and managing diseases caused by bioterrorism agents.
"Most American physicians in practice today have never seen any cases of these diseases in their practice," explained Dr. Sara Cosgrove, a faculty member in Hopkins' Division of Infectious Diseases. "Preparation will be key to dealing with a major catastrophe, such as a major bioterrorist attack."
In the study, physicians at 30 internal medicine residency programs in 16 states and Washington, D.C. were tested on how to recognize and treat bioterrorism-related diseases before and after taking an online course in bioterrorism disease. Correct management of such diseases in the pretest averaged 25.4 percent. Upon completion of the course, correct management averaged 79 percent.
The study is detailed in the Sept. 26 issue of Archives of Internal Medicine.
Copyright 2005 by United Press International
Related stories:
Rapid test for pathogens developed by K-State researchers
Dangerous disease often spreads faster than it takes to diagnose it in the lab. To remedy that, researchers at Kansas State University have developed a test to bring that time from days down to hours.
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco. The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous molecular conversations, is likely to extend to many other disorders in which cell-signaling pathways are disrupted.
Reason for sickness absence can predict employee deaths
Employees who take long spells of sick leave more than once in three years are at a higher risk of death than their colleagues who take no such absence, particularly if their absence is due to circulatory or psychiatric problems or for surgery, concludes a study on bmj.com today.
Healthy blood vessels may prevent fat growth
The cells lining blood vessels are known to be important for maintaining health, but researchers at the Indiana University School of Medicine believe these cells may perform an unsuspected task – controlling the development of fat cells. Their findings are reported in the September issue of the journal
Stem Cells.
Researcher micro-sizes genetics testing
Using new "lab on a chip" technology, James Landers hopes to create a hand-held device that may eventually allow physicians, crime scene investigators, pharmacists, even the general public to quickly and inexpensively conduct DNA tests from almost anywhere, without need for a complex and expensive central laboratory.
Researchers evaluate cost-effectiveness of genetic screening to guide initial HIV treatment
A major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions. The new recommendation suggests conducting a genetic screening test prior to prescribing the drug abacavir, one of the preferred first-line drugs for the treatment for HIV-infected adults.
Is re-emerging superbug the next MRSA?
Dr. Ed Corboy had no idea what was afflicting his 80-year-old mother, Joan Corboy. All he knew for certain was that since being treated for what was a routine diarrheal infection, she seemed to be wasting away and none of her doctors or other health specialists could explain why.
Wistar researchers invigorate 'exhausted' immune cells
In battles against chronic infections, the body's key immune cells often become exhausted and ineffective. Researchers at The Wistar Institute have found a way to restore vigor to these killer T cells by blocking a key receptor on their surface, findings that may advance the development of new therapies for diseases such as HIV, hepatitis B and C, and cancer.